Literature DB >> 7124772

Herpes simplex type 2 virus encephalitis presenting as psychosis.

K J Oommen, P C Johnson, C G Ray.   

Abstract

The current literature recognizes two antigenic types of herpes simplex virus, type 1 and 2. Type 1 is the most common cause of sporadic necrotizing encephalitis in the United States, with a mortality rate of 30 to 70 percent, and leaves various neurologic sequelae in the survivors. Herpes simplex virus type 2 had been recognized as an etiologic agent in fatal infections in neonates and a mild meningitis in adults, but its role in encephalitis in adults is less well known. We report a case of herpes simplex virus type 2 encephalitis with an analysis of four additional cases previously documented in the literature. Herpes simplex virus type 2 may cause more infections than is presently recognized, and we suggest that some cases of acute psychosis may, like in our case, represent herpes simplex virus type 2 encephalitis.

Entities:  

Mesh:

Year:  1982        PMID: 7124772     DOI: 10.1016/0002-9343(82)90751-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Is serodiagnosis of herpes simplex encephalitis safe?

Authors:  J G Coghlan; C Monaghan; P A Carney; J H Moran
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

Review 2.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

3.  Acute bacterial meningitis in young adults mistaken for substance abuse.

Authors:  L N Baldwin; A Henderson; P Thomas; M Wright
Journal:  BMJ       Date:  1993-03-20

4.  Detection of herpes simplex virus DNA from cerebrospinal fluid by PCR and a rapid, nonradioactive hybridization technique.

Authors:  H H Kessler; K Pierer; B Weber; A Sakrauski; B Santner; D Stuenzner; E Gergely; E Marth
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

Review 5.  Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations.

Authors:  Norbert Müller
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 6.  Cognitive outcome in acute sporadic encephalitis.

Authors:  L Hokkanen; J Launes
Journal:  Neuropsychol Rev       Date:  2000-09       Impact factor: 6.940

Review 7.  Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.

Authors:  Thalia F van der Doef; Janine Doorduin; Bart N M van Berckel; Simon Cervenka
Journal:  Clin Transl Imaging       Date:  2015-09-10

Review 8.  The role of inflammation in schizophrenia.

Authors:  Norbert Müller; Elif Weidinger; Bianka Leitner; Markus J Schwarz
Journal:  Front Neurosci       Date:  2015-10-21       Impact factor: 4.677

Review 9.  Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis.

Authors:  Meike Heurich; Melanie Föcking; David Mongan; Gerard Cagney; David R Cotter
Journal:  Mol Psychiatry       Date:  2021-07-05       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.